FGF21 and metabolic dysfunction-associated steatohepatitis: In modern research, FGF21’s importance matches clinical validation studies showing its upregulation in MASH patients and the therapeutic potential of FGF21 analogs in enabling both MASH resolution and fibrosis improvement [47,64,65,66,67,68,69,70,71].